TY - BOOK PY - 2011 DA - 2011// TI - Global strategy and plan of action on public health, innovation and intellectual property PB - World Health Organization CY - Geneva ID - ref1 ER - TY - BOOK AU - Losse, K. AU - Schneider, E. AU - Spennemann, C. PY - 2007 DA - 2007// TI - The viability of local pharmaceutical production in Tanzania PB - Deutsche Gesellschaft für Technische Zusammenarbeit (GTZ) GmbH CY - Eschborn ID - Losse2007 ER - TY - BOOK AU - Chaudhuri, S. PY - 2005 DA - 2005// TI - The WTO and India’s Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries PB - Oxford University Press CY - New Delhi ID - Chaudhuri2005 ER - TY - BOOK PY - 2011 DA - 2011// TI - Local production for access to medical products: developing a framework to improve public health PB - World Health Organization CY - Geneva ID - ref4 ER - TY - BOOK AU - Kaplan, W. AU - Laing, R. PY - 2005 DA - 2005// TI - Local production of pharmaceuticals: industrial policy and access to medicines. An overview of key concepts, issues and opportunities for future research, in HNP Discussion Paper PB - The World Bank CY - Washington ID - Kaplan2005 ER - TY - BOOK PY - 2011 DA - 2011// TI - Investment in Pharmaceutical Production in the Least Developed Countries: A Guide for Policymakers and Investment Promotion Agencies PB - United Nations CY - Geneva ID - ref6 ER - TY - BOOK PY - 2004 DA - 2004// TI - World Medicines Situation PB - World Health Organization CY - Geneva ID - ref7 ER - TY - JOUR AU - Kaplan, W. A. AU - Ritz, L. S. AU - Vitello, M. PY - 2011 DA - 2011// TI - Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literature JO - Southern Med Rev VL - 4 UR - https://doi.org/10.5655/smr.v4i2.1002 DO - 10.5655/smr.v4i2.1002 ID - Kaplan2011 ER - TY - JOUR AU - Mujinja, P. G. PY - 2014 DA - 2014// TI - Local production of pharmaceuticals in Africa and access to essential medicines: ‘urban bias’ in access to imported medicines in Tanzania and its policy implications JO - Glob Health VL - 10 UR - https://doi.org/10.1186/1744-8603-10-12 DO - 10.1186/1744-8603-10-12 ID - Mujinja2014 ER - TY - JOUR AU - Timmermans, K. PY - 2004 DA - 2004// TI - Harmonization, regulation, and trade: interactions in the pharmaceutical field JO - Int J Health Serv VL - 34 UR - https://doi.org/10.2190/3JQK-0D1K-FVNC-9W2A DO - 10.2190/3JQK-0D1K-FVNC-9W2A ID - Timmermans2004 ER - TY - JOUR AU - Abraham, J. AU - Reed, T. PY - 2001 DA - 2001// TI - Trading risks for markets: the international harmonization of pharmaceuticals regulation JO - Health Risks Soc VL - 3 UR - https://doi.org/10.1080/713670172 DO - 10.1080/713670172 ID - Abraham2001 ER - TY - JOUR AU - Grimes, D. A. PY - 2005 DA - 2005// TI - The Good Clinical Practice guideline: a bronze standard for clinical research JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)66875-4 DO - 10.1016/S0140-6736(05)66875-4 ID - Grimes2005 ER - TY - CHAP PY - 2002 DA - 2002// TI - The Impact of Implementation of ICH Guidelines in Non-ICH Countries BT - Regulatory Support Series, No. 9 PB - World Health Organization CY - Geneva ID - ref13 ER - TY - BOOK AU - Santhosh, M. AU - Singh, A. PY - 2009 DA - 2009// TI - Booklet on Access to Medicines in India PB - CLRA-Centad CY - New Delhi ID - Santhosh2009 ER - TY - BOOK PY - 2011 DA - 2011// TI - WHO Expert Committee on Specifications for Pharmaceutical Preparations, in WHO Technical Report Series ID - ref15 ER - TY - STD TI - WHO. Guidelines on the implementation of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce. 2014 [cited 2014 July 3]; Available from: http://www.who.int/medicines/areas/quality_safety/regulation_legislation/certification/guidelines/en/. UR - http://www.who.int/medicines/areas/quality_safety/regulation_legislation/certification/guidelines/en/ ID - ref16 ER - TY - STD TI - PIC/S. Pharmaceutical Inspection Co-operation Scheme: Role. 2014 [cited 2014 July 14]; Available from: http://www.picscheme.org. UR - http://www.picscheme.org ID - ref17 ER - TY - BOOK PY - 2010 DA - 2010// TI - Annex 2: WHO good manufacturing practices for active pharmaceutical ingredients in WHO Technical Report Series PB - World Health Organization CY - Geneva ID - ref18 ER - TY - BOOK PY - 2010 DA - 2010// TI - Assessment of medicines regulatory systems in 26 sub-Saharan African countries: An overview of findings from 26 assessment reports PB - World Health Organization CY - Geneva ID - ref19 ER - TY - BOOK PY - 2008 DA - 2008// TI - Drug Safety: Better Data Management and More Inspections Are Needed to Strengthen FDA’s Foreign Drug Inspection Program PB - United States Government Accountability Office CY - Washington, D.C ID - ref20 ER - TY - STD TI - Global Fund. 6th Invitation to manufacturers of antimalarial medicines to submit an Expression of Interest (EoI) for product evaluation by Expert Review Panel (ERP). 2011. ID - ref21 ER - TY - BOOK PY - 2008 DA - 2008// TI - Fiscal year 2008: PEPFAR operational Plan ID - ref22 ER - TY - STD TI - Blake S et al. U.N. Commission on Life Saving Commodities for Women and Children:Country Case Studies. 2012. [cited 2015 June 7]; Available from: http://can-mnch.ca/wp-content/uploads/2012/06/Life-Saving-Commodities-New_Concept_Note1.pdf. ID - ref23 ER - TY - BOOK AU - Hill, S. AU - Johnson, K. PY - 2004 DA - 2004// TI - Emerging challenges and opportunities in drug registration and regulation in developing countries PB - DFID Health Systems Resource Centre CY - London ID - Hill2004 ER - TY - JOUR AU - Brhlikova, P. PY - 2011 DA - 2011// TI - Trust and the regulation of pharmaceuticals: South Asia in a globalised world JO - Glob Health VL - 7 UR - https://doi.org/10.1186/1744-8603-7-10 DO - 10.1186/1744-8603-7-10 ID - Brhlikova2011 ER - TY - JOUR AU - Meshkini, A. H. PY - 2012 DA - 2012// TI - Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study JO - DARU J Pharm Sci VL - 20 UR - https://doi.org/10.1186/2008-2231-20-19 DO - 10.1186/2008-2231-20-19 ID - Meshkini2012 ER - TY - JOUR AU - Pinheiro, E. S. PY - 2014 DA - 2014// TI - Production of antiretroviral drugs in middle- and low-income countries JO - Antivir Ther VL - 19 UR - https://doi.org/10.3851/IMP2900 DO - 10.3851/IMP2900 ID - Pinheiro2014 ER - TY - JOUR AU - Abdo-Rabbo, A. AU - Bassili, A. AU - Atta, H. PY - 2005 DA - 2005// TI - The quality of antimalarials available in Yemen JO - Malar J VL - 4 UR - https://doi.org/10.1186/1475-2875-4-28 DO - 10.1186/1475-2875-4-28 ID - Abdo-Rabbo2005 ER - TY - BOOK AU - Trouiller, P. AU - Folb, P. AU - Weerasuriya, K. PY - 2001 DA - 2001// TI - Legal and regulatory issues affecting drug development for neglected diseases: harmonization of technical requirements for registration of pharmaceuticals for human use ID - Trouiller2001 ER - TY - BOOK AU - Trouiller, P. PY - 2002 DA - 2002// TI - The globalisation of regulatory requirements, and the development and availability of medicinal products in developing countries: quality, efficacy and safety issues ID - Trouiller2002 ER - TY - BOOK PY - 2010 DA - 2010// TI - Independent evaluation: Strengthening the local production of essential generic drugs in least developed/developing countries PB - UNIDO CY - Vienna ID - ref31 ER - TY - BOOK AU - Guimier, J. -. M. AU - Lee, E. AU - Grupper, M. PY - 2004 DA - 2004// TI - Processes and issues for improving access to medicines: the evidence base for domestic production and greater access to medicines PB - DFID Health Systems Resource Centre CY - London ID - Guimier2004 ER - TY - JOUR AU - WHO, W. H. O. PY - 2014 DA - 2014// TI - Prequalification: Building quality-assured manufacturing capacity in Nigeria JO - WHO Drug Inf VL - 28 ID - WHO2014 ER - TY - STD TI - WHO. WHO List of Prequalified Medicinal Products. 2015 [cited 2015 17 April]; Available from: http://apps.who.int/prequal/query/ProductRegistry.aspx. UR - http://apps.who.int/prequal/query/ProductRegistry.aspx ID - ref34 ER - TY - STD TI - WHO. WHO List of Prequalified Active Pharmaceutical Ingredients. 2015 [cited 2015 April 17]; Available from: http://apps.who.int/prequal/info_applicants/API_PQ-List.htm. UR - http://apps.who.int/prequal/info_applicants/API_PQ-List.htm ID - ref35 ER - TY - BOOK AU - Dixit, H. PY - 2000 DA - 2000// TI - Nepal’s Quest for Health PB - Educational Books Publishing (P) Ltd CY - Kathmandu ID - Dixit2000 ER - TY - BOOK PY - 2006 DA - 2006// TI - WTO and public health policy priorities for Nepal PB - SAWTEE CY - Kathmandu ID - ref37 ER - TY - BOOK PY - 2012 DA - 2012// TI - Quality assurance of medicines in Nepal: identified needs for capacity enhancement PB - Deutsche Gesellschaft für Internationale ZusammenarbeitHealth Sector Support Programme CY - Kathmandu ID - ref38 ER - TY - BOOK AU - Budhathoki, S. PY - 2012 DA - 2012// TI - Drug Drive: The Rising Business of Pharmaceutical Companies in Nepal, in New Business Age ID - Budhathoki2012 ER - TY - BOOK PY - 2007 DA - 2007// TI - Department of Drug Administration: Objectives ID - ref40 ER - TY - BOOK PY - 2011 DA - 2011// TI - Nepal Pharmaceutical Country Profile ID - ref41 ER - TY - STD TI - Jeffery R. Tracing Pharmaceuticals in South Asia: Project Design and Basic Data. 2010. [cited 2015 June 7]; Available from: http://www.csas.ed.ac.uk/__data/assets/pdf_file/0005/49244/Tracing_Pharmaceuticals_in_South_Asia_WP2010.pdf. ID - ref42 ER - TY - JOUR PY - 2004 DA - 2004// TI - Editorial: GMP Certification for Assuring the Quality of Pharmaceutical Products JO - Drug Bull Nepal VL - 16 ID - ref43 ER - TY - STD TI - DDA. Regulatory news. Drug Bulletin of Nepal. 2012;24(1) ID - ref44 ER - TY - BOOK AU - Shrestha, B. PY - 2012 DA - 2012// TI - Nepal National Health Accounts, 2006/2007 - 2008/2009 PB - Health Economics and Financing Unit, Ministry of Health and Population, Government of Nepal CY - Kathmandu ID - Shrestha2012 ER - TY - STD TI - Mosites E, et al. Nepal zinc case study. University of Washington Global Health START Program; 2012 ect.org/sites/default/files/resources/Nepal_Zinc%20Case%20Study_0.pdf. ID - ref46 ER - TY - BOOK AU - Toledo, E. PY - 2009 DA - 2009// TI - USP DQI Good Manufacturing Practices Assessment for Manufacturers of Zinc Sulfate Tablets and Chlorhexidine Kathmandu, Nepal; January 14–22, 2008 PB - Submitted to the U.S. Agency for International Development by the United States Pharmacopeia Drug Quality and Information Program CY - Rockville, Maryland: United States Pharmacopeia ID - Toledo2009 ER - TY - JOUR AU - Palaian, S. AU - Mishra, P. PY - 2005 DA - 2005// TI - Role of drug and therapeutics committee towards drug safety–experiences from western Nepal JO - Kathmandu Univ Med J (KUMJ) VL - 3 ID - Palaian2005 ER - TY - CHAP AU - Shakya, B. ED - Gallagher, P. ED - Low, P. ED - Stoler, A. PY - 2005 DA - 2005// TI - Nepal: Exports of Ayurvedic Herbal Remedies and SPS Issues BT - Managing the Challenges of WTO Participation: 45 Case Studies PB - Cambridge University Press CY - Cambridge ID - Shakya2005 ER - TY - JOUR AU - Morimoto, K. PY - 2003 DA - 2003// TI - Promoting GMP implementation: developing training materials for the international audience JO - Qual Assur. VL - 10 ID - Morimoto2003 ER - TY - JOUR AU - Harper, I. AU - Rawal, N. AU - Subedi, M. PY - 2011 DA - 2011// TI - Disputing distribution: ethics and pharmaceutical regulation in Nepal JO - Studies Nepali Hist Soc. VL - 16 ID - Harper2011 ER -